Dexcom (DXCM) Other Non-Current Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Other Non-Current Liabilities data on file, last reported at $141.8 million in Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $141.8 million, down 5.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $141.8 million (down 5.66% YoY), and the FY2025 annual result was $137.1 million, down 7.3% from the prior year.
• Other Non-Current Liabilities climbed to $141.8 million in Q1 2026 per DXCM's latest filing, from $137.1 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $151.6 million in Q2 2025 and troughed at $97.1 million in Q1 2022.
• A 5-year average of $131.4 million and a median of $129.7 million in 2023 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities soared 42.56% in 2022, then fell 7.3% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $128.3 million in 2022, then retreated by 2.1% to $125.6 million in 2023, then gained by 17.75% to $147.9 million in 2024, then decreased by 7.3% to $137.1 million in 2025, then climbed by 3.43% to $141.8 million in 2026.
• Business Quant data shows DXCM's Other Non-Current Liabilities at $141.8 million in Q1 2026, $137.1 million in Q4 2025, and $147.4 million in Q3 2025.